Archive of outdated tools from Challenge TB, TB CARE I, TB CAP and partners
Archive of outdated tools from Challenge TB, TB CARE I, TB CAP and partners
A collection of country-approved tools that are applied in the TB IC demonstration site in Zambia. In some cases globally available tools have been modified to take into consideration local needs and conditions. Other tools had to be developed. All the tools are adaptable for use.
Effective TB Infection Control Safety without stigma.
The estimation and projection of costs are essential for the planning, budgeting, financing and evaluation of TB services. To meet this need TB CARE I has developed four costing tools which are presented in this four-page document.
The TB Economic Burden Analysis Tool allows the user to estimate the economic burden of TB to families and society as a while. It comprises the cost of service delivery, patient cost (such as transport), and productivity losses due to illness and premature death. It is intended for advocacy and has been used in Indonesia for that purpose (see report) – The package contains two excel files, one filled example and one empty version.
The TB Services Costing Tool allows the user to develop 10 year cost projections based on incidence and treatment targets for TB and MDR-TB and more years can be added if necessary. It has been used in Indonesia to develop national cost estimates for national strategic planning and also to develop cost estimates for Central Java Province – The package contains two excel files, one filled example and one empty version.
An analysis of national claims data obtained from the public health insurance schemes, and carried out series of interviews with health and insurance managers, and non-governmental organizations in 3 Indonesian provinces – Aceh, Jakarta and West Java.
To assist the Indonesian NTP to analyze and project service delivery costs, a simple, user-friendly costing tool was developed for use by national, district and provincial program managers. The tool was developed because there was no existing tool suitable for sub-national levels, and it was tested in Central Java, a large province with 32 million people.
To facilitate the development and implementation of the exit strategy for TB, it is necessary to have a good understanding of the cost of current and future services at all levels so that the necessary domestic funding can be provided and areas can be identified where greater efficiency and cost-effectiveness might be achieved. To assist the NTP to analyze and project service delivery costs, a simple, user-friendly costing tool was developed for use by national, district and provincial program managers. The tool was developed because there was no existing tool suitable for sub-national levels, and it was tested in Central Java and the resulting model was then used to estimate the projected costs for the whole country.
A major challenge in increasing government budget allocations is the lack of understanding of the economic burden caused by TB and the savings that can be achieved with a successful and well-resourced TB program. Being able to provide estimates of the economic burden will provide evidence that can strengthen the ability of the NTP and the Ministry of Health to advocate for the funding needed. This report looks into the economic burden of TB in Indonesia.
This WHO manual encourages countries to accept and implement basic concepts in biological safety and to develop national codes of practice for the safe handling of pathogenic microorganisms in laboratories within their geographical borders. This is the third edition which adds new chapters on risk assessment, safe use of recombinant DNA technology and transport of infectious materials.
Le diagnostique et le suivi du traitement par l’examen microscopique de frottis réalisés sur des crachats est la pierre de voute de la stratégie DOTS. La couverture de population plus nombreuse par le DOTS requiert le renforcement des structures de laboratoire et de leur capacité à fournir de services fiables et de haute qualité. Ce document couvre l’ensemble des informations minimales requises pour mener à bien une évaluation utile d’un réseau de laboratoire.
Rapid Implementation of the Xpert MTB/RIF diagnostic test – Technical and Operational ‘How-to’ Practical considerations.
Nigeria, Indonesia and Kazakhstan were selected as initial TB CARE I countries for rapid implementation of Xpert MTB/RIF. They receive intensified technical support from March 2011 to March 2013. A final report was written describing the overall process of Xpert MTB/RIF implementation, challenges, lessons learnt and way forward for each individual country, as well as for TB CARE I in general.
Laboratory Assessment Form (English)
This Roadmap shows how in 37 Steps GeneXpert can be implemented successfully.
The key lessons learnt during the implementation of TB CARE I activities in Uganda, have been captured for use by other TB management programs in Uganda and other countries. The lessons were generated over a 6 month period using a combination of methods such as review of project documents and reports, discussions with project staff and other stakeholders and interviews with TB and health program managers within the Kampala City Council Authority (KCCA) and the NTLP.
The objective of this compendium is to encourage and facilitate internal and external M&E of TB control programs to improve quality and effectiveness.
This report provides a description of the set-up and development of the two country specific projects. It provides the local recommendations that were given during the year to strengthen the national systems and enhance data capture and quality of data. The report also provides extensive analysis and results of the collected data and the conclusions and final recommendations to the National TB Programs for each of the projects.
The purpose of this document is to guide tuberculosis programme supervisors and others interested in Routine Data Quality Assessment (RDQA) for TB monitoring. Such people may come from district hospitals/centres, health centres and health posts; the intermediate level (regional/provincial); or the monitoring and evaluation unit at central level (the national TB program).
This guide is aimed at health workers, who manage sick children in first level health facilities or outpatient setting at any level of care and NTP worker who manage children as part of NTP work. It aims to improve early and accurate case detection of children with TB, the management and outcome of children with TB and child contact screening and management. It focuses on diagnosis of common forms of TB in children, how to treat, when to refer and the management of children who are close contacts of TB cases.
A detailed analysis of and lessons from Global Fund PPM projects, focusing particularly on scaled-up program. This analysis will benefit not only the countries scaling-up or planning to scale-up PPM for TB care and control but also the technical and financial partners who advise and support countries in PPM scale-up.
These are the results of a project to assess the availability of surveillance childhood TB data, collect these data to feed into the newly produced global estimates of childhood TB, and to produce a snapshot of the structure for the management of childhood TB at country level, stakeholders involved and challenges faced regarding implementation of childhood TB activities at country level.
The Management and Organizational Sustainability Tool for National TB Control programs (MOST for TB) is a process for improving the management of an NTP. MOST can be used at any level of a national TB Control Program that would like to strengthen program management in order to improve implementation and expansion of the Stop TB strategy.
La Herramienta de Administración y Sustentabilidad Organizacional para Programas Nacionales de Control de la TB (MOST para la TB) es un proceso para mejorar la administración de un PNCT, cuyo resultado final es contribuir a lograr los tres objetivos principales de los PNCT.
This publication captures the experiences, initiatives and innovative solutions of countries attending the platform meeting in June 2008. It can be used a resource for future reference and for triggering innovative solutions for those unable to attend the platform meetings.
This publication captures the experiences, initiatives and innovative solutions of countries attending the platform meeting in June 2009. It can be used a resource for future reference and for triggering innovative solutions for those unable to attend the platform meetings
The purpose of this document is to outline a strategy for management of human resources for tuberculosis control specifying the role of national TB programmes as well as the support by international organizations and agencies.
This pocket guide is designed to provide practitioners useful in- formation for the clinical management of MDR-TB patients. It draws from WHO international guidelines whenever possible and WHO guidelines do not cover a specific topic, it provides recommendations based on interpretations of cohort studies, clinical trials, case reports, and personal experience.
Цель этого руководства состоит в том, чтобы предоставить практикующим врачам полезную информацию по клиниче- скому ведению больных МЛУ-ТБ. По мере возможности мы получали информацию из международных руководств ВОЗ. В случаях, когда руководства ВОЗ не охватывали конкрет- ной темы, мы предоставляли рекомендации, основанные на нашей интерпретации данных когортных исследований, кли- нических испытаний, клинических случаев и личного опыта.
A guide to the creation of a simple, generic and user-friendly model accessible by NTP managers at national and local levels for conducting cost and cost-effective analysis of MDT-TB diagnostic and treatment services for the conduction of an analysis in Indonesia, but applicable in a global context.
This is a simple, user-friendly, generic tool that is available for countries to use to compare the cost-effectiveness of different diagnoses and treatment methods for MDR-TB. The tool builds on previous studies on cost-effectiveness of MDR-TB, and on WHO guidelines on cost and cost-effectiveness analysis of TB control. It can be used to compare the costs and effectiveness of different treatment strategies from the provider perspective. For outcome measures the tool uses case completion rate, the cure rate and the cost of deaths averted. The intended users are district, provincial and central level TB program managers and planners.